34
Participants
Start Date
August 1, 2011
Primary Completion Date
June 20, 2016
Study Completion Date
January 20, 2019
Trastuzumab
Trastuzumab will be administered twice per week for 4 weeks, then once per week for 4 weeks, and then every 2 weeks
Columbia University, New York
Memorial Sloan-Kettering Cancer Center, New York
Northwestern University, Chicago
Texas Oncology-Austin, Austin
University of California San Francisco (UCSF), San Francisco
Tufts Medical Center, Boston
Dana Farber Cancer Institute, Boston
Rhode Island Hospital, Providence
Northwestern University
OTHER